Document is current

Article History

Received: 1 October 2024

Accepted: 10 December 2024

First Online: 20 December 2024

Declarations

:

: Giovanni Corrao received research support from the European Community (EC), the Italian Agency of Drug (AIFA), and the Italian Ministry for University and Research (MIUR). He took part in various projects funded by pharmaceutical companies (i.e., Novartis, GSK, Roche, AMGEN, and BMS). He also received honoraria as a member of the Advisory Board from Roche. The remaining authors declare that the research was conducted without commercial or financial relationships that could be construed as potential conflicts of interest. The other authors have no conflict of interest to declare. We affirm that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of any organization or company.

: According to the rules from the Italian Medicines Agency (available at: ), retrospective studies without direct contact with patients do not need written consent to process personal data when they are used for research aims.

Free to read: This content has been made available to all.